Tetracycline Capsules

[13 October 2014]

Products Affected - Description

Tetracycline capsules, Teva
250 mg, 100 count (NDC 00172-2416-60)
250 mg, 1000 count (NDC 00172-2416-80)
500 mg, 100 count (NDC 00172-2407-60)
500 mg, 1000 count (NDC 00172-2407-80)

Reason for the Shortage

  • Due to the shortage, combination products that contain oral tetracycline may be affected as well.
  • Heritage launched tetracycline capsules in October 2013. 
  • Teva states tetracycline capsules are unavailable due to a raw material shortage.
  • Watson discontinued tetracycline capsules in October 2013. The company could not provide a reason for the discontinuation.

Available Products

Tetracycline capsules, Heritage
250 mg, 100 count (NDC 23155-0017-01)
500 mg, 100 count (NDC 23155-0018-01)

Estimated Resupply Dates

Teva has all tetracycline capsules temporarily discontinued and the company cannot estimate a release date.

Related Shortages


October 13, 2014; July 17, 2014; April 10, 2014; January 9, 2014; October 25, 2013; October 24, 2013; August 1, 2013; June 6, 2013; April 4, 2013; February 1, 2013; January 9, 2013; October 2, 2012; June 28, 2012; March 20, 2012; February 27, 2012; February 1, 2012; January 18, 2012; December 6, 2011; October 4, 2011; September 15, 2011; September 14, 2011; August 11, 2011, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
ASHP Product Listing